when does the patent on semaglutide expire Last week's expiry of for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions Semaglutide & Tirzepatide Patent Considerations
Pay in 4 interest-free payments of $5.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28



























